Filter

Showing 1–12 of 33 results

2020 FDA Approvals Adalimumab
+
 Quick View

anti-human

Adalimumab Biosimilar – Research Grade [ICH4001]

$704.00 – $4,080.00
2020 FDA Approvals Ado-trastuzumab-emtansine
+
 Quick View

anti-human

Ado-trastuzumab emtansine Biosimilar – Research Grade [ICH4014]

$1,122.00 – $2,550.00
2020 FDA Approvals Aflibercept
+
 Quick View

anti-human

Aflibercept Biosimilar – Research Grade [ICH4015]

$1,122.00 – $2,550.00
2020 FDA Approvals for Alemtuzumab
+
 Quick View

anti-human

Alemtuzumab Biosimilar – Research Grade [ICH4002]

$704.00 – $4,080.00
2020 FDA Approvals Alirocumab
+
 Quick View

anti-human

Alirocumab Biosimilar – Research Grade [ICH4016]

$704.00 – $4,080.00
2020 FDA Approvals Atezolizumab
+
 Quick View

anti-human

Atezolizumab Biosimilar – Research Grade [ICH4018]

$704.00 – $4,080.00
2020 FDA Approvals Avelumab
+
 Quick View

anti-human

Avelumab Biosimilar – Research Grade [ICH4017]

$704.00 – $4,080.00
2020 FDA Approvals Bevacizumab
+
 Quick View

anti-human

Bevacizumab Biosimilar – Research Grade [ICH4003]

$704.00 – $4,080.00
2020 FDA Approvals Cetuximab
+
 Quick View

anti-human

Cetuximab Biosimilar – Research Grade [ICH4004]

$704.00 – $4,080.00
2020 FDA Approvals Daratumumab
+
 Quick View

anti-human

Daratumumab Biosimilar – Research Grade [ICH4020]

$4,080.00 – $35,700.00
2020 FDA Approvals Denosumab
+
 Quick View

anti-human

Denosumab Biosimilar – Research Grade [ICH4019]

$704.00 – $4,080.00
2020 FDA Approvals Eculizumab
+
 Quick View

anti-human

Eculizumab Biosimilar – Research Grade [ICH4005]

$704.00 – $4,080.00